SEMAGLUTIDE 2.25MG (0.9 mg/mL) recall
FDA recall D-0748-2026 · initiated Jul 29, 2026
Apollo Care, LLC recalled SEMAGLUTIDE 2.25MG (0.9 mg/mL) in Jul 2026 — an FDA Class II recall (D-0748-2026) because Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material.
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Something got into the product
A physical or chemical contaminant was found — glass or metal fragments, or a solvent that should not be there.
This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.
Is your product affected? Check the lot number
A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.
Quantity recalled: 23,029 vials.
Details
- Product
- SEMAGLUTIDE 2.25MG (0.9 mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202 NDC 71170-811-02
- Recalling company
- Apollo Care, LLC
- Classification
- Class II
- Status
- Ongoing
- Type
- Voluntary: Firm initiated
- Distribution
- Nationwide within the U.S
- Initiated
- Jul 29, 2026
- FDA report date
- Aug 19, 2026
Frequently asked
- Was SEMAGLUTIDE 2.25MG (0.9 mg/mL) recalled?
- Apollo Care, LLC recalled SEMAGLUTIDE 2.25MG (0.9 mg/mL) in Jul 2026 — an FDA Class II recall (D-0748-2026) because Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material. May cause temporary or medically reversible harm; low probability of serious harm.
- Why was SEMAGLUTIDE 2.25MG (0.9 mg/mL) recalled?
- Per the FDA enforcement record, the reason for recall D-0748-2026 was: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
- Is a recalled SEMAGLUTIDE 2.25MG (0.9 mg/mL) dangerous to take?
- An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
- Which lots of SEMAGLUTIDE 2.25MG (0.9 mg/mL) are affected?
- Distributed: Nationwide within the U.S. The recall covers these lots — Lot: AC-017114, Exp. 11/24/2026; AC-017164, AC-017204, AC-017205, Exp. 12/31/2026.. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0748-2026.